Answers are grounded in this paper and cite their sources.
BACKGROUND: Granulocyte-colony stimulating factor (G-CSF) is one of the most important pharmacologically used proteins. Potential uses beyond the stimulation of neutrophilic granulocytes are the treatment of CNS disorders. Disadvantages of the G-CSF protein as a drug are its moderate plasma half-life time and considerable production costs. We therefore conducted a screen for peptide agonists derived from the sequence of human G-CSF. FINDINGS: Despite of the high sensitivity of our screening system we could not detect any positive hits in a single peptide approach. In a multiplex approach using a permutation of any combination of 10 different peptides we could also not detect a positive block. CONCLUSIONS: We conclude that larger coherent parts of the protein or dimerising peptides may be needed to achieve activation of the receptor.
No takes yet. Share an insight, caveat, or question.
Conzelmann et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: